AsCNP/JSNP/JSCNP 2019

Presentation information

Print

[NP] Symposium

NP » [NP] Symposium

[NP_S4] Symposium 4
To reconsider schizophrenia

Sat. Oct 12, 2019 2:50 PM - 4:30 PM Room 4 (409)

オーガナイザー・座長：菊地　哲朗（大塚製薬株式会社医薬品事業部）、座長：石郷岡　純（CNS薬理研究所）

3:40 PM - 4:04 PM

[NP-S4-3] SEP-363856, a novel psychotropic agent with a non-D2 mechanism of action

○Kazuki YABUUCHI1, Kenneth KOBLAN2, Robert GOLDMAN2, Justine KENT2, Seth HOPKINS2, Antony LOEBEL2 (1. Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd., Tokyo, Japan, 2. Sunovion Pharmaceuticals Inc.)

Abstract password authentication.
Password to browse/download the abstracts has been sent to pre-registrants by email and printed on name badge. It is also indicated in the abstract booklet.

Password